Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways
- PMID: 33152487
- DOI: 10.1016/j.semcancer.2020.10.012
Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways
Abstract
Research over decades has enabled us in developing a better understanding of the multifaceted and heterogeneous nature of cancer. High-throughput technologies have helped the researchers in unraveling of the underlying mechanisms which centrally regulate cancer onset, metastasis and drug resistance. Our rapidly expanding knowledge about signal transduction cascade has added another layer of complexity to already complicated nature of cancer. Deregulation of cell signaling pathways played a linchpin role in carcinogenesis and metastasis. Cucurbitacins have gained tremendous attention because of their remarkable pharmacological properties and considerable ability to mechanistically modulate myriad of cell signaling pathways in different cancers. In this review, we have attempted to provide a mechanistic and comprehensive analysis of regulation of oncogenic pathways by cucurbitacins in different cancers. We have partitioned this review into separate sections for exclusive analysis of each signaling pathway and critical assessment of the knowledge gaps. In this review, we will summarize most recent and landmark developments related to regulation of Wnt/β-catenin, JAK/STAT, mTOR, VEGFR, EGFR and Hippo pathway by cucurbitacins. Moreover, we will also address how cucurbitacins regulate DNA damage repair pathway and TRAIL-driven signaling in various cancers. However, there are still outstanding questions related to regulation of SHH/GLI, TGF/SMAD and Notch-driven pathway by cucurbitacins in different cancers. Future studies must converge on the analysis of full-fledge potential of cucurbitacins by in-depth analysis of these pathways and how these pathways can be therapeutically targeted by cucurbitacins.
Keywords: Apoptosis; Cancer; Nutrigenomics.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Similar articles
-
Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways.Pharmacol Res. 2020 Oct;160:105188. doi: 10.1016/j.phrs.2020.105188. Epub 2020 Sep 9. Pharmacol Res. 2020. PMID: 32919041 Review.
-
EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways.Cancers (Basel). 2020 Apr 12;12(4):951. doi: 10.3390/cancers12040951. Cancers (Basel). 2020. PMID: 32290543 Free PMC article. Review.
-
Multifunctional Roles of Betulinic Acid in Cancer Chemoprevention: Spotlight on JAK/STAT, VEGF, EGF/EGFR, TRAIL/TRAIL-R, AKT/mTOR and Non-Coding RNAs in the Inhibition of Carcinogenesis and Metastasis.Molecules. 2022 Dec 21;28(1):67. doi: 10.3390/molecules28010067. Molecules. 2022. PMID: 36615262 Free PMC article. Review.
-
Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs.Molecules. 2023 Feb 27;28(5):2231. doi: 10.3390/molecules28052231. Molecules. 2023. PMID: 36903477 Free PMC article. Review.
-
Regulation of cell signaling pathways by circular RNAs and microRNAs in different cancers: Spotlight on Wnt/β-catenin, JAK/STAT, TGF/SMAD, SHH/GLI, NOTCH and Hippo pathways.Semin Cell Dev Biol. 2022 Apr;124:72-81. doi: 10.1016/j.semcdb.2021.04.002. Epub 2021 Apr 15. Semin Cell Dev Biol. 2022. PMID: 33863643 Review.
Cited by
-
Stemness-related genes revealed by single-cell profiling of naïve and stimulated human CD34+ cells from CB and mPB.Clin Transl Med. 2023 Jan;13(1):e1175. doi: 10.1002/ctm2.1175. Clin Transl Med. 2023. PMID: 36683248 Free PMC article.
-
Molecular basis of acute coronary syndrome.J Res Med Sci. 2022 May 30;27:40. doi: 10.4103/jrms.jrms_695_21. eCollection 2022. J Res Med Sci. 2022. PMID: 35968216 Free PMC article. Review.
-
Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer.Cancers (Basel). 2022 Sep 12;14(18):4423. doi: 10.3390/cancers14184423. Cancers (Basel). 2022. PMID: 36139582 Free PMC article. Review.
-
Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer.Clin Transl Oncol. 2021 Nov;23(11):2220-2236. doi: 10.1007/s12094-021-02639-0. Epub 2021 Jul 18. Clin Transl Oncol. 2021. PMID: 34275108 Review.
-
Acylglycerol Kinase-Targeted Therapies in Oncology.Front Cell Dev Biol. 2021 Jul 22;9:659158. doi: 10.3389/fcell.2021.659158. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34368119 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous